The agreement covers the creation and sale of rodent animal models, the sale of existing rodent animal models and sublicensing rights
Cellectis (Alternext: ALCLS), the genome engineering specialist, and genOway (Alternext: ALGEN), the animal model specialist, today announce an exclusive agreement under which genOway becomes the exclusive provider of Cellectis’ homologous recombination technology for research applications in genetically modified rodents.Cellectis will remain the partner for any other applications, such as bioproduction and therapeutics. Financial details were not disclosed. genOway is recognized by the industry as the leader in high-value research models for candidate drug evaluation...
Genevac reports on a protocol that describes a rapid, safe technique for drying oligonucleotide and DNA samples.
DNA and oligonucleotide samples are sensitive and care needs to be exercised during concentration. Research done at the Welcome Trust Centre for Human Genetics (UK) shows that the Genevac EZ-2 evaporator is an ideal tool for concentrating SNP and oligonucleotides in microplates when preparing samples for microarraying and for Sequenon analysis. Compared to traditional methods, using the EZ-2 evaporator is shown to significantly speed up concentration rates, eliminate potential sources of damage to samples and also improve final sample quality...
Quality-driven tender selects OGT after extensive validation
Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics. Involving the cooperation of a number of health authorities, the tender’s comprehensive validation process sets an excellent example for future procurement procedures...
Spanish biotechnology company Midatech Bioguneis taking advantage of Syrris Atlas Potassium reactor systems to produce custom-made functionalized gold nanoparticles for medicinal use.
Midatech’s CEO, Justin Barry, explained: “Midatech is a clinical stage biotechnology company focused on translating its proprietary gold nanoparticle drug delivery platform into effective nanomedicines targeting currently unmet medical needs. We begin by producing functionalized gold nanoparticles on a bench scale, then move to larger scale manufacturing processes, where it makes sense to use a reactor system. Our Atlas Potassium reactors, with pH control and an Atlas Syringe Pump XL, have allowed us to scale-up production, enabling variables such as pH and temperature to be tightly controlled...
Thermo Fisher Scientific has developed a rapid and robust high-performance anion-exchange chromatography
With pulsed amperometric detection method for the accurate determination of common sugars in acid-hydrolyzed biomass samples with high carbohydrate concentrations. Application Update 192: Carbohydrate Determination of Biofuel Samples demonstrates that this approach has a linear range suitable for handling high-concentration biomass samples with minimal sample treatment. This new method is fast, provides good sensitivity, has consistent response, and can be routinely used to determine carbohydrates in the feedstock for biofuel production...
Ultra-sensitive PointMan™ enables blood sampling instead of tissue biopsies for cancer patient mutation status assessment
EKF Diagnostics, the global in vitro diagnostics business, announces a major breakthrough for its PointMan™ DNA enrichment technology for potential use in future cancer testing and treatment. The first successful results of a collaboration between EKF Molecular Diagnostics and the Institute of Life Sciences at Swansea University have demonstrated the detection of gene mutations in blood from samples archived in the Wales Cancer Bank....
Group's Gift Will Save Animals, Improve Medical Training
Thousands of animals on three continents will soon be spared being cut apart and killed in medical training courses, thanks to PETA US' unprecedented donation of $1 million (£610,000) in simulators to countries in Latin America, the Middle East and Asia. PETA US, through a landmark partnership with Seattle-based medical simulation manufacturer Simulab, is modernising medical training around the world with a donation of 64 state-of-the-art TraumaMan surgical simulators to replace the crude use of animals in deadly trauma training exercises completely in nine countries...
Freeman Technology shows latest applications for FT4 Powder Rheometer® at PITTCON 2014 Booth #814
Powder characterisation specialists from Freeman Technology will be at PITTCON 2014 (March 2-6 2014, McCormick Place, Chicago) where the company is exhibiting the FT4 Powder Rheometer®. Firmly established as the most comprehensive powder characterisation system available, the FT4 Powder Rheometer is used across many industrial sectors, from pharmaceuticals to bulk powders. The system delivers data that support process and product understanding and the optimisation of powder processes...
Standardising Cleanroom Production Line Monitoring for Microbial Contamination
Synergy Health’s Applied Sterilisation Technologies (AST) laboratory services are using Cherwell Laboratories’ SAS Pinocchio compressed air and bottled gas sampler to deliver an enhanced service to its customers. Synergy’s microbiological laboratories offer a wide range of services within the medical device and pharmaceutical manufacturing industries, including environmental monitoring, sterilisation validation and bioburden analysis. The introduction of Cherwell’s SAS Pinocchio is enabling Synergy to help their customers meet regulatory requirements more effectively...
Raster Orbital Scanning Technology from Ocean Optics Recognised at TASIA Awards
The Raster Orbital Scanning (ROS) feature of the IDRaman family of products from Ocean Optics has been recognized as one of 2013’s 15 best innovation technologies by The Analytical Scientist magazine, an industry publication. ROS is a novel Raman spectroscopy sampling technique that helps to derive more accurate and comprehensive measurement results. The IDRaman mini handheld Raman spectrometer and the IDRaman reader integrated Raman spectrometer both feature ROS...
For 55 years, Fluid Metering, Inc. has been providing their unique valveless, ceramic piston pump design for precision fluid control in Laboratory, Process, and Industrial applications.
In addition, FMI’s miniature OEM pumps have proven ideal for micro-volume fluid control in analytical, medical, and process analyzers and instrumentation. FMI’s newly released 2014 Full Line Catalog contains new products as well as expanded flow and configuration information. FMI’s New “Intelligent” Programmable Pump is a compact stepper pump with integral programmable driver electronics.....
A technical article is available from Genevac that describes a rapid, safe technique for drying oligonucleotide and DNA samples.
DNA and oligonucleotide samples are sensitive and care needs to be exercised during concentration. Research done at the Welcome Trust Centre for Human Genetics (UK) shows that the Genevac EZ-2 evaporator is an ideal tool for concentrating SNP and oligonucleotides in microplates when preparing samples for microarraying and for Sequenon analysis. Compared to traditional methods, using the EZ-2 evaporator is shown to significantly speed up concentration rates, eliminate potential sources of damage to samples and also improve final sample quality...
A pioneering scanning technique that can image a patient’s entire body can reveal where cancer is affecting the bones and guide doctors in their choice of treatment, new research reveals.
The new type of magnetic resonance imaging (MRI) scan could improve care for a type of cancer called myeloma and reduce reliance on bone marrow biopsies, which can be painful for patients and often fail to show doctors how far the disease has spread. The research is published today (Tuesday) in the journal Radiology and was carried out by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust....
Olympus launches its OlyVIA Mobile iPad App, an image viewer dedicated to virtual slides.
Allowing fast and easy-to-use remote viewing, the free-to-download app conveniently displays large brightfield as well as multidimensional fluorescence images. Researchers and educators are now able to access their entire library of virtual microscope images with just a tap of the finger on the OlyVIA Mobile iPad App. Free to download from the iTunes App Store, the app is designed for images captured with the Olympus VS120 virtual slide scanning system....
The Sunday Times Fast Track listing has recognised Kinapse as one of the UK’s fastest growing companies. Kinapse is also the fastest growing life sciences company to feature in the 2013 Fast Track 100.
Kinapse helps the world’s largest life science companies to bring new medicines to patients and to support the monitoring of medicines’ safety and effectiveness once approved. The company has a unique model which deploys global expertise in strategic advisory services, change management and operational support services. To support its exceptional growth, Kinapse is expanding its operations in US, Europe and India and this month opened new offices in New York and Bangalore. Kinapse is actively recruiting experienced life sciences professionals in all of these locations...
Waters Introduces UPLC System for nano- to Microscale Separations – the ACQUITY UPLC M-Class System
New UPLC System and Columns Drive Separations Efficiency and the Sensitivity of LC-MS Analyses to New Levels. Waters Corporation (WAT:NYSE) today introduced the new Waters® ACQUITY UPLC® M-Class System, an industry-first nano- to microscale UltraPerformance LC® (UPLC®) system rated for 15,000 psi operation. Coupled to Waters mass spectrometers, the system delivers the sensitivity to quantify and to identify vanishingly small concentrations of key molecules....
As global concern grows over drug-resistant infections and the prevalence of infectious diseases, researchers are looking to enhance capabilities for pathogen detection, infection diagnosis and genomic analysis of disease-causing micro-organisms.
With this, Oxford Global Conferences are proud to the present the first ever Microbiology & Infectious Diseases Asia Congress, taking place on the 10 & 11 June 2014 in Singapore. This event is an executive platform for experts working in microbiology, bacteriology, mycology, virology and parasitology in Asia Pacific. There will be up to 50 presentations and cases studies that is presented through four interactive streams that focuses on Detection Technology & Molecular Diagnostics, Clinical Microbiology, Microbial Genomics and Infectious Diseases...
Porvair Filtration has strengthened its position as a leading sintered porous metal manufacturer with the acquisition of Eisenmann Metallurgical LLC
Porvair Filtration Group, the specialist filtration and separations group, has strengthened its position as a leading sintered porous metal manufacturer with the acquisition of Eisenmann Metallurgical LLC, trading as Chand Eisenmann Metallurgical (CEM). CEM designs and manufactures specialized filters and flow restrictors at a facility located in Caribou, Maine (USA). There is a good commercial fit between CEM and Porvair's existing sintered porous metal filter product portfolio...
Spark Holland B.V. is pleased to announce the publication of US patent no. US 8586382 B2 which relates to a method and an apparatus for desorption of a blood sample from a medical test sheet comprising at least one dried blood spot (DBS) for the purpose of biomedical analysis of the blood sample. The patent allows that the new method eliminates the need for first punching out a disc area of the test sheet containing dried blood sample, thus speeding up the procedure considerably and that on-line desorption of dried blood spots is faster and easier and allows for further automation of the process.
FRITSCH Milling and Sizing steadily progresses forward: besides the subsidiary in the Chinese capital Beijing, now an office was opened in Shanghai.
Since decades FRITSCH is involved in international markets and of course also in the Chinese market. In order to serve the growing customer base in a continuative, flexible, and customer oriented manner a subsidiary was founded directly in Shanghai. Two markets at once will be managed from Shanghai: The South Chinese market as well as Hong Kong which is only 120 km away. End of 2013, barely a year after the opening of the subsidiary in Beijing, the official opening ceremony for the office in Shanghai was held. FRITSCH employees Li Xiao, Diels Ding and Sala Bian welcomed customers from economy, research as well as employees and FRITSCH partners...
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers
Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have renewed their partnership with the aim of identifying therapeutic targets for treating ‘triple negative’ breast cancers. The partnership will continue for a further three years. ‘Triple negative’ breast cancers account for around 15 per cent of breast cancer cases. They are particularly aggressive and can be unresponsive to the current chemotherapy regimens; hence the urgent need to find new therapies...
Discovery Park Enterprise Zone in East Kent has been awarded more than £6 million to transform buildings and create labs.
The share in a £100 million nationwide infrastructure fund is designed to stimulate job creation – the zone’s target is 3,000 by 2017 - and even faster growth, Discovery Park, the former Pfizer site near Sandwich, will invest the money in the refurbishment, redesign and fitting out of three vacant buildings – or parts of buildings – for employment use. The decision was being confirmed today (January 29) by Stephen Williams, the Communities Minister, during a visit to the park. He will be holding talks with park managing director Paul Barber, touring the site and meeting leaders of Pfizer and Algaecytes...
Cellectis (Alternext: ALCLS), the genome engineering specialist, and genOway (Alternext: ALGEN), the animal model specialist, today announce an exclusive agreement under which genOway becomes the exclusive provider of Cellectis’ homologous recombination technology for research applications in genetically modified rodents.Cellectis will remain the partner for any other applications, such as bioproduction and therapeutics. Financial details were not disclosed. genOway is recognized by the industry as the leader in high-value research models for candidate drug evaluation...
Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics. Involving the cooperation of a number of health authorities, the tender’s comprehensive validation process sets an excellent example for future procurement procedures...
EKF Diagnostics, the global in vitro diagnostics business, announces a major breakthrough for its PointMan™ DNA enrichment technology for potential use in future cancer testing and treatment. The first successful results of a collaboration between EKF Molecular Diagnostics and the Institute of Life Sciences at Swansea University have demonstrated the detection of gene mutations in blood from samples archived in the Wales Cancer Bank....
Thousands of animals on three continents will soon be spared being cut apart and killed in medical training courses, thanks to PETA US' unprecedented donation of $1 million (£610,000) in simulators to countries in Latin America, the Middle East and Asia. PETA US, through a landmark partnership with Seattle-based medical simulation manufacturer Simulab, is modernising medical training around the world with a donation of 64 state-of-the-art TraumaMan surgical simulators to replace the crude use of animals in deadly trauma training exercises completely in nine countries...
Synergy Health’s Applied Sterilisation Technologies (AST) laboratory services are using Cherwell Laboratories’ SAS Pinocchio compressed air and bottled gas sampler to deliver an enhanced service to its customers. Synergy’s microbiological laboratories offer a wide range of services within the medical device and pharmaceutical manufacturing industries, including environmental monitoring, sterilisation validation and bioburden analysis. The introduction of Cherwell’s SAS Pinocchio is enabling Synergy to help their customers meet regulatory requirements more effectively...
The new type of magnetic resonance imaging (MRI) scan could improve care for a type of cancer called myeloma and reduce reliance on bone marrow biopsies, which can be painful for patients and often fail to show doctors how far the disease has spread. The research is published today (Tuesday) in the journal Radiology and was carried out by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust....
Spark Holland B.V. is pleased to announce the publication of US patent no. US 8586382 B2 which relates to a method and an apparatus for desorption of a blood sample from a medical test sheet comprising at least one dried blood spot (DBS) for the purpose of biomedical analysis of the blood sample. The patent allows that the new method eliminates the need for first punching out a disc area of the test sheet containing dried blood sample, thus speeding up the procedure considerably and that on-line desorption of dried blood spots is faster and easier and allows for further automation of the process.
Since decades FRITSCH is involved in international markets and of course also in the Chinese market. In order to serve the growing customer base in a continuative, flexible, and customer oriented manner a subsidiary was founded directly in Shanghai. Two markets at once will be managed from Shanghai: The South Chinese market as well as Hong Kong which is only 120 km away. End of 2013, barely a year after the opening of the subsidiary in Beijing, the official opening ceremony for the office in Shanghai was held. FRITSCH employees Li Xiao, Diels Ding and Sala Bian welcomed customers from economy, research as well as employees and FRITSCH partners...
The share in a £100 million nationwide infrastructure fund is designed to stimulate job creation – the zone’s target is 3,000 by 2017 - and even faster growth, Discovery Park, the former Pfizer site near Sandwich, will invest the money in the refurbishment, redesign and fitting out of three vacant buildings – or parts of buildings – for employment use. The decision was being confirmed today (January 29) by Stephen Williams, the Communities Minister, during a visit to the park. He will be holding talks with park managing director Paul Barber, touring the site and meeting leaders of Pfizer and Algaecytes...